|
|
|
|
| LEADER |
01546cam a2200457 4500 |
| 001 |
PPN005262429 |
| 003 |
http://www.sudoc.fr/005262429 |
| 005 |
20150318021200.0 |
| 010 |
|
|
|a 0-7484-0557-7
|
| 020 |
|
|
|a US
|b 96157155
|
| 020 |
|
|
|a GB
|b 96-32205
|
| 035 |
|
|
|a (OCoLC)489701547
|
| 035 |
|
|
|a sib0734383
|
| 035 |
|
|
|a ocm34675817
|
| 035 |
|
|
|z ocm35600265
|
| 100 |
|
|
|a 19960716d1996 k y0frey0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a GB
|a US
|
| 105 |
|
|
|a a z 000yy
|
| 106 |
|
|
|a r
|
| 200 |
1 |
|
|a Potassium channels and their modulators
|b Texte imprimé
|e from synthesis to clinical experience
|f ed. J.M. Evans, T. C. Hamilton, S. D. Longman... [et al.]
|
| 210 |
|
|
|a London
|a Bristol [Etats-Unis]
|c Taylor & Francis
|d 1996
|
| 215 |
|
|
|a xiv-424 p.
|d 24 cm
|
| 225 |
2 |
|
|a Taylor & Francis series in pharmaceutical sciences
|
| 320 |
|
|
|a Notes bibliogr. Index
|
| 410 |
|
| |
|0 013600508
|t Taylor & Francis series in pharmaceutical sciences
|c London [etc]
|n Taylor & Francis
|d 1996-...
|
| 606 |
|
|
|3 PPN040802876
|a Canaux potassiques
|2 fmesh
|
| 606 |
|
|
|3 PPN031450156
|a Canaux potassiques
|2 rameau
|
| 606 |
|
|
|3 PPN028942035
|a Canaux ioniques
|2 rameau
|
| 676 |
|
|
|a 615.7
|v 20
|
| 680 |
|
|
|a QP535.K1
|b P656 1996
|
| 686 |
|
|
|a 1996 M-717
|2 usnlm
|
| 686 |
|
|
|a QH 603.I54
|b P8592 1996
|2 usnlm
|
| 702 |
|
1 |
|a Evans
|b J.M
|4 340
|
| 801 |
|
3 |
|a FR
|b SF
|g AFNOR
|
| 801 |
|
1 |
|a US
|b OCLC
|g AACR2
|
| 801 |
|
2 |
|a FR
|b AUROC
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20150317
|g AFNOR
|
| 979 |
|
|
|a SAN
|
| 930 |
|
|
|5 441092101:524198225
|b 441092101
|a 11769
|j u
|
| 998 |
|
|
|a 198450
|
Nantilus
